全文获取类型
收费全文 | 4292篇 |
免费 | 410篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 133篇 |
妇产科学 | 80篇 |
基础医学 | 624篇 |
口腔科学 | 180篇 |
临床医学 | 479篇 |
内科学 | 727篇 |
皮肤病学 | 70篇 |
神经病学 | 260篇 |
特种医学 | 172篇 |
外科学 | 621篇 |
综合类 | 102篇 |
一般理论 | 3篇 |
预防医学 | 379篇 |
眼科学 | 37篇 |
药学 | 252篇 |
中国医学 | 3篇 |
肿瘤学 | 557篇 |
出版年
2021年 | 64篇 |
2020年 | 49篇 |
2019年 | 69篇 |
2018年 | 85篇 |
2017年 | 64篇 |
2016年 | 43篇 |
2015年 | 67篇 |
2014年 | 93篇 |
2013年 | 155篇 |
2012年 | 194篇 |
2011年 | 174篇 |
2010年 | 106篇 |
2009年 | 91篇 |
2008年 | 160篇 |
2007年 | 170篇 |
2006年 | 175篇 |
2005年 | 163篇 |
2004年 | 156篇 |
2003年 | 140篇 |
2002年 | 146篇 |
2001年 | 127篇 |
2000年 | 138篇 |
1999年 | 137篇 |
1998年 | 79篇 |
1997年 | 68篇 |
1996年 | 51篇 |
1995年 | 50篇 |
1994年 | 49篇 |
1993年 | 54篇 |
1992年 | 89篇 |
1991年 | 104篇 |
1990年 | 101篇 |
1989年 | 97篇 |
1988年 | 95篇 |
1987年 | 76篇 |
1986年 | 87篇 |
1985年 | 71篇 |
1984年 | 53篇 |
1983年 | 45篇 |
1981年 | 39篇 |
1980年 | 43篇 |
1979年 | 53篇 |
1978年 | 38篇 |
1976年 | 38篇 |
1973年 | 57篇 |
1972年 | 43篇 |
1971年 | 40篇 |
1970年 | 31篇 |
1969年 | 37篇 |
1967年 | 37篇 |
排序方式: 共有4716条查询结果,搜索用时 15 毫秒
71.
72.
Bakakos P Smith JL Warner JO Vance G Moss CT Hodges E Lanham S Howell WM 《The Journal of allergy and clinical immunology》2001,107(6):1089-1094
BACKGROUND: Peanut is one of the most common foods causing allergic reactions and is the most common cause of fatal and near-fatal food-related anaphylaxis. Little is known of the immunologic mechanisms that underlie peanut allergy. OBJECTIVES: In this study we examined clonality of the T-cell response (TCR) to peanut in MHC class II identical, peanut allergy-discordant sibling pairs. METHODS: Four sibling pairs were investigated. The TCR repertoire was analyzed before and after in vitro stimulation of PBMCs with crude peanut or PHA, as control for general/nonspecific reactivity. Eighteen TCR-Vbeta families were examined by flow cytometry. Where significant differences in incidence of particular TCR-Vbeta families were observed, PCR familyspecific cDNA amplification and gene scanning were performed. RESULTS: After stimulation with peanut, no selective expansion of any TCR-Vbeta subpopulation was observed with flow cytometry, in either the peanut-allergic or nonallergic siblings, with the exception of 1 peanut-allergic subject who demonstrated a significant increase of TCR-Vbeta11(+) cells (0.3%-5.9% of the total CD3(+) cells). However, gene scanning revealed predominant single-size PCR products for TCRBV11 in all peanut-allergic subjects after peanut stimulation. TCRBV11 polyclo-nality was observed in allergic and nonallergic subjects before peanut stimulation and in nonallergic subjects after peanut stimulation. In comparison, all subjects, before and after stimulation with peanut, showed polyclonality for TCRBV2. CONCLUSIONS: Our results argue for clonal or oligoclonal TCRs to crude peanut and indicate that changes in the TCRBV11 subpopulation are restricted to peanut-allergic subjects after stimulation with crude peanut allergen. 相似文献
73.
A group-specific,indirect sandwich ELISA for the detection of equine encephalosis virus antigen 总被引:2,自引:0,他引:2
Crafford JE Guthrie AJ van Vuuren M Mertens PP Burroughs JN Howell PG Hamblin C 《Journal of virological methods》2003,112(1-2):129-135
A polyclonal antibody-based, group-specific, indirect, sandwich ELISA (S-ELISA) for the detection of equine encephalosis virus (EEV) antigen was developed. Purified EEV particles were titrated in the S-ELISA and the limit of detection was determined to be approximately 9.0 ng of antigen/ml (0.45 ng/well). Positive S-ELISA reactions were recorded with seven serologically distinct EEV serotypes. No cross-reactions were recorded with other arboviruses including African horse sickness virus (AHSV) serotypes 1-9, bluetongue serotypes 1-24, epizootic haemorrhagic disease serotypes 1-8 and isolate 318, and selected isolates of Palyam, Eubenangee, Corriparta, Warrego, Akabane and bovine ephemeral fever viruses. The assay proved to be sensitive and specific for the rapid detection of EEV in cell cultures and in homogenated suckling mouse brain (MB). The data generated in this study suggest that the ELISA will be valuable for epidemiological studies of EE and will assist in making a reliable differential diagnosis between EEV and AHSV infections. 相似文献
74.
75.
76.
77.
Restructuring Primary Health Care Markets in New Zealand: from Welfare Benefits to Insurance Markets
Background
New Zealand's Primary Health Care Strategy (NZPHCS) was introduced in 2002. Its features are substantial increases in government funding delivered as capitation payments, and newly-created service-purchasing agencies. The objectives are to reduce health disparities and to improve health outcomes.Analysis
The NZPHCS changes New Zealand's publicly-funded primary health care payments from targeted welfare benefits to universal, risk-rated insurance premium subsidies. Patient contributions change from fee-for-service top-ups to insurance premium top-ups, and are collected by service providers who, depending upon their contracts with purchasers, may also be either insurance agents or risk-bearing insurance companies. The change invokes the tensions associated with allocating risk-bearing amongst providers, patients and insurance companies that accompany all insurance-based funding instruments. These include increases in existing incentives for over-consumption and new incentives for insurers to limit their exposure to variations in patient health states by engaging in active patient pool selection.The New Zealand scheme is complex, but closely resembles United States insurance-based, risk-rated managed care schemes. The key difference is that unlike classic managed care models, where provider remuneration is determined by the insurer, the historic right for general practitioners to autonomously set patient charges alters the fiscal incentives normally available to managed care organisations. Consequently, the insurance role is being devolved to individual service providers with very small patient pools, who must recoup the premium top-ups from insured individuals. Premium top-ups are being collected only from those individuals consuming care, in proportion to the number of times care is sought. Co-payments thus constitute perfectly risk-rated premium levies set by inefficiently small insurers, raising questions about the efficiency and equity of a 'universal' insurance system pooling total population demands and costs. The efficacy of using financial incentives to constrain costs and encourage innovation when providers retain the right to arbitrarily recoup costs directly from patients, is also questioned.Results
Initial evidence suggests that total costs are higher than initially expected, and prices to some patients have risen substantially under the NZPHCS. Limited competition and NZPHCS governance requirements mean current institutional arrangements are unlikely to facilitate efficiency improvements. System design changes therefore appear indicated.78.
The authors developed a Web-based mission-based reporting (MBR) system for their university's (UC Davis's) health system to report faculty members' activities in research and creative work, clinical service, education, and community/university service. They developed the system over several years (1998-2001) in response to a perceived need to better define faculty members' productivity for faculty development, financial management, and program assessment. The goal was to create a measurement tool that could be used by department chairs to counsel faculty on their performances. The MBR system provides measures of effort for each of the university's four missions. Departments or the school can use the output to better define expenditures and allocations of resources. The system provides both a quantitative metric of times spent on various activities within each mission, and a qualitative metric for the effort expended. The authors report the process of developing the MBR system and making it applicable for both clinical and basic science departments, and the mixed success experienced in its implementation. The system appears to depict the activities of most faculty fairly accurately, and chairs of test departments have been generally enthusiastic. However, resistance to general implementation remains, chiefly due to concerns about reliability, validity, and time required for completing the report. The authors conclude that MBR can be useful but will require some streamlining and the elimination of other redundant reporting instruments. A well-defined purpose is required to motivate its use. 相似文献
79.
Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial. 总被引:5,自引:0,他引:5
W J Cohn J J Boylan R V Blanke M W Fariss J R Howell P S Guzelian 《The New England journal of medicine》1978,298(5):243-248
Industrial workers exposed to the organochlorine pesticide, chlordecone (Kepone), had signs of toxicity in several organs. The extent of toxicity was proportional to the levels of this chemical in the tissues. In 22 patients, chlordecone was eliminated slowly from blood (half time of 165 +/- 27 days--mean +/- S.E.M.) and fat (half time of 125 days, with a range of 97 to 177), chiefly in the stool. Output of chlordecone in bile was 10 to 20 times greater than in stool, suggesting that chlordecone is reabsorbed in the "ntestine. Cholestyramine, an anion-exchange resin that binds chlordecone, increased its fecal excretion by seven times. In a five-month trial, cholestyramine significantly accelerated elimination of chlordecone from blood, with a half life of 80 +/- 4 days (S.E.M.) (P less than 0.005) and fat (half life of 64 days, with a range of 52 to 85) (P less than 0.05). Cholestyramine offers a practical means for detoxification of persons exposed to chlordecone and possibly to other lipophilic toxins. 相似文献
80.
Petros Bakakos MDa John L. Smith PhDb John O. Warner MDa Gillian Vance MRCPa Christine T. Moss BScb Elizabeth Hodges PhDb Stuart Lanham PhDb W. Martin Howell PhDb 《The Journal of allergy and clinical immunology》2001,107(6):1089
Background: Peanut is one of the most common foods causing allergic reactions and is the most common cause of fatal and near-fatal food-related anaphylaxis. Little is known of the immunologic mechanisms that underlie peanut allergy. Objectives: In this study we examined clonality of the T-cell response (TCR) to peanut in MHC class II identical, peanut allergy–discordant sibling pairs. Methods: Four sibling pairs were investigated. The TCR repertoire was analyzed before and after in vitro stimulation of PBMCs with crude peanut or PHA, as control for general/nonspecific reactivity. Eighteen TCR-Vβ families were examined by flow cytometry. Where significant differences in incidence of particular TCR-Vβ families were observed, PCR familyspecific cDNA amplification and gene scanning were performed. Results: After stimulation with peanut, no selective expansion of any TCR-Vβ subpopulation was observed with flow cytometry, in either the peanut-allergic or nonallergic siblings, with the exception of 1 peanut-allergic subject who demonstrated a significant increase of TCR-Vβ11+ cells (0.3%-5.9% of the total CD3+ cells). However, gene scanning revealed predominant single-size PCR products for TCRBV11 in all peanut-allergic subjects after peanut stimulation. TCRBV11 polyclo-nality was observed in allergic and nonallergic subjects before peanut stimulation and in nonallergic subjects after peanut stimulation. In comparison, all subjects, before and after stimulation with peanut, showed polyclonality for TCRBV2.Conclusions: Our results argue for clonal or oligoclonal TCRs to crude peanut and indicate that changes in the TCRBV11 subpopulation are restricted to peanut-allergic subjects after stimulation with crude peanut allergen. (J Allergy Clin Immunol 2001;107:1089-94.) 相似文献